 randomized placebo-controlled trial erythromycin treatment Ureaplasma urealyticum premature delivery Vaginal Infections Prematurity Study Group Ureaplasma urealyticum low birth weight histologic chorioamnionitis frequent isolate chorioamnion patients prior clinical trials antibiotics active urealyticum antibiotic treatment reduced prematurity mean birth weight multicenter double-blind clinical trial pregnant women urealyticum mg erythromycin base placebo times weeks gestation completed weeks pregnancy Women urinary tract infection Neisseria gonorrhoeae infection trial women Chlamydia trachomatis group streptococci analyses Erythromycin urealyticum genital tract significant differences erythromycin- placebo-treated women infant birth gestational age delivery frequency premature rupture membranes neonatal outcome